Hillman Company’s Nautilus Biotechnolgy NAUT Stock Holding History

Hillman Company’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Hold	200,000	–	–	0.13%	14
2026 Q1	$776K	Hold	200,000	–	–	0.3%	14
2025 Q4	$390K	Hold	200,000	–	–	0.14%	15
2025 Q3	$169K	Hold	200,000	–	–	0.05%	15
2025 Q2	$145K	Hold	200,000	–	–	0.06%	14
2025 Q1	$172K	Hold	200,000	–	–	0.07%	14
2024 Q4	$336K	Hold	200,000	–	–	0.14%	13
2024 Q3	$570K	Hold	200,000	–	–	0.25%	13
2024 Q2	$468K	Hold	200,000	–	–	0.22%	12
2024 Q1	$588K	Hold	200,000	–	–	0.27%	12
2023 Q4	$598K	Hold	200,000	–	–	0.28%	14
2023 Q3	$632K	Hold	200,000	–	–	0.38%	13
2023 Q2	$774K	Hold	200,000	–	–	0.44%	11
2023 Q1	$554K	Hold	200,000	–	–	0.27%	13
2022 Q4	$360K	Hold	200,000	–	–	0.19%	14
2022 Q3	$424K	Hold	200,000	–	–	0.22%	13
2022 Q2	$538K	Hold	200,000	–	–	0.26%	15
2022 Q1	$868K	Hold	200,000	–	–	0.32%	13
2021 Q4	$1.04M	Hold	200,000	–	–	0.38%	12
2021 Q3	$1.23M	Hold	200,000	–	–	0.43%	10
2021 Q2	$2.02M	Buy	+200,000	New	+$2.17M	0.52%	12

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Hillman Company's NAUT Position: Q2 2026 in Review

Hillman Company held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 200,000 shares worth $374K. The position accounts for 0.13% of the portfolio, ranked #14.

Hillman Company first reported a position in NAUT in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.02M in Q2 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Hillman Company held 200,000 shares of Nautilus Biotechnolgy worth $374K as of Q2 2026.
Hillman Company left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
Nautilus Biotechnolgy made up 0.13% of Hillman Company's portfolio in Q2 2026, its #14 holding.
Hillman Company first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 21 quarters since.
Hillman Company's Nautilus Biotechnolgy position peaked at $2.02M in Q2 2021.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Hillman Company's 13F filing for Q2 2026, filed 27 Jul 2026.